Literature DB >> 24506539

Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation.

Russell C Dale1, Alice Gardiner, Joceline A Branson, Henry Houlden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24506539     DOI： 10.1111/dmcn.12396

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  4 in total

1.  PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity.

Authors:  Floriana Fruscione; Pierluigi Valente; Bruno Sterlini; Alessandra Romei; Simona Baldassari; Manuela Fadda; Cosimo Prestigio; Giorgia Giansante; Jacopo Sartorelli; Pia Rossi; Alicia Rubio; Antonio Gambardella; Thierry Nieus; Vania Broccoli; Anna Fassio; Pietro Baldelli; Anna Corradi; Federico Zara; Fabio Benfenati
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

2.  Familial Hemiplegic Migraine with an ATP1A4 Mutation: Clinical Spectrum and Carbamazepine Efficacy.

Authors:  Giangennaro Coppola; Grazia Maria Giovanna Pastorino; Luigi Vetri; Floriana D'Onofrio; Francesca Felicia Operto
Journal:  Brain Sci       Date:  2020-06-15

Review 3.  Genomic testing in pediatric epilepsy.

Authors:  Drew M Thodeson; Jason Y Park
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-08-01

4.  Comprehensive Exonic Sequencing of Hemiplegic Migraine-Related Genes in a Cohort of Suspected Probands Identifies Known and Potential Pathogenic Variants.

Authors:  Heidi G Sutherland; Neven Maksemous; Cassie L Albury; Omar Ibrahim; Robert A Smith; Rod A Lea; Larisa M Haupt; Bronwyn Jenkins; Benjamin Tsang; Lyn R Griffiths
Journal:  Cells       Date:  2020-10-28       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.